Pirarubicin
Sponsors
Japan Adult Leukemia Study Group, Guangxi Medical University, 307 Hospital of PLA, Peking University First Hospital, Peking University People's Hospital
Conditions
0.5-14 Year Old Children With NephroblastomaBladder RecurrenceBreast CancerBreast NeoplasmsHepatocellular CarcinomaLymphoblastic Leukemia, AcuteNephroureterectomyOsteosarcoma
Phase 1
Phase 2
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053
Start: 2002-09-30End: 2011-09-30Target: 120Updated: 2008-11-14
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma
WithdrawnNCT02585479
Start: 2015-10-31End: 2017-10-31Updated: 2019-06-04
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02740426
Start: 2016-08-31End: 2022-05-31Target: 200Updated: 2017-09-21
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients
NCT02923557
Start: 2016-11-30Target: 200Updated: 2016-11-17
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
WithdrawnNCT03342300
Start: 2017-11-06End: 2020-12-30Updated: 2020-05-19
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
RecruitingNCT06714383
Start: 2024-11-13End: 2025-11-30Target: 50Updated: 2024-12-03